Reliability and validity of a new scale on internal coherence (ICS) of cancer patients
Open Access
- 24 June 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Health and Quality of Life Outcomes
- Vol. 7 (1), 59
- https://doi.org/10.1186/1477-7525-7-59
Abstract
Background Current inventories on quality of life used in oncology mainly focus on functional aspects of patients in the context of disease adaption and treatments (side) effects (EORTC QLQ C30) or generically the status of common functions (Medical Outcome Study SF 36). Beyond circumscribed dimensions of quality of life (i.e., physical, emotional, social, cognitive etc.), there is a lack of inventories which also address other relevant dimensions such as the 'sense of coherence' (SOC) in cancer patients. SOC is important because of its potential prognostic relevance in cancer patients, but the current SOC scale has mainly been validated for psychiatric and psychosomatic patients. Our two-step validation study addresses the internal coherence (ICS) scale, which is based on expert rating, using specific items for oncological patients, with respect to its reliability, validity and sensitivity to chemotherapy. Methods The items were tested on 114 participants (57 cancer patients and a matched control group), alongside questions on autonomic regulation (aR), the Hospital Anxiety and Depression Scale (HADS), self-regulation (SRQ) and Karnofsky the Performance-Index (KPI). A retest of 65 participants was carried out after a median time span of four weeks. In the second part of the study, the ICS was used to assess internal coherence during chemotherapy in 25 patients with colorectal carcinoma (CRC) and 17 breast cancer patients. ICS was recorded before, during and 4 – 8 weeks after treatment. Results The 10-item scale of 'internal coherence' (ICS) shows good to very good reliability: Cronbach-α r = 0.91, retest-reliability r = 0.80. The ICS correlates with r = 0.43 – 0.72 to the convergence criteria (all p < 0.001). We are able to show decreased ICS-values after the third cycle for CRC and breast cancer patients, with a subsequent increase of ICS scores after the end of chemotherapy. Conclusion The ICS has good to very good reliability, validity and sensitivity to chemotherapy.Keywords
This publication has 34 references indexed in Scilit:
- Validation of a questionnaire measuring the regulation of autonomic functionBMC Complementary and Alternative Medicine, 2008
- Sense of coherence and diabetes: A prospective occupational cohort studyBMC Public Health, 2008
- Sense of coherence as a resource in relation to health-related quality of life among mentally intact nursing home residents - a questionnaire studyHealth and Quality of Life Outcomes, 2008
- Validation of the German version of the Cancer Fatigue Scale (CFS-D)European Journal of Cancer Care, 2007
- Adaptation to Social Adversity Is Associated With Stroke IncidenceStroke, 2007
- Antonovsky's sense of coherence scale and the relation with health: a systematic reviewJournal of Epidemiology and Community Health, 2006
- Quality of life in patients who survive a dire prognosis compared to control cancer survivorsPsycho‐Oncology, 2004
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- Coefficient alpha and the internal structure of testsPsychometrika, 1951